Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma-Reference-Cited by-同舟云学术

Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma

Published:2012-02 Issue:2 Volume:75 Page:261-267
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Woods Beth,Paracha Noman,Scott David A.,Thatcher Nicholas

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Health and Safety Executive. Mesothelioma. Available from: http://www.hse.gov.uk/statistics/causdis/mesothelioma/ [assessed 01.04.11].

2. Projection of mesothelioma mortality in Great Britain;Tan,2009

3. Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Stahel;Ann Oncol,2010

4. Final appraisal determination – pemetrexed for the treatment of malignant pleural mesothelioma;National Institute for Health and Clinical Excellence,2007

5. Health technology appraisal. Final scope – pemetrexed disodium for the treatment of malignant pleural mesothelioma;National Institute for Health and Clinical Excellence,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma;British Journal of Cancer;2024-03-22

2. Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as the first-line treatment for unresectable malignant pleural mesothelioma;Therapeutic Advances in Medical Oncology;2022-01

3. A Novel Formulation of Cisplatin with γ-Polyglutamic Acid and Chitosan Reduces Its Adverse Renal Effects: An In Vitro and In Vivo Animal Study;Polymers;2021-05-30

4. Analysis of pemetrexed-based chemotherapy in the treatment of advanced colorectal cancer;Annals of Translational Medicine;2020-11

5. The relationship between treatment cost and prognosis of malignant pleural mesothelioma in Turkey;Eurasian Journal of Pulmonology;2019